Endocrinology, Vol 137, 879-885, Copyright © 1996 by Endocrine Society

ARTICLES

Insulin-like growth factors I and II stimulate extracellular matrix production in human glomerular mesangial cells. Comparison with transforming growth factor-beta

F Pricci, G Pugliese, G Romano, G Romeo, N Locuratolo, F Pugliese, P Mene, G Galli, A Casini, CM Rotella and U Di Mario
Department of Experimental Medicine, La Sapienza University, Rome, Italy.

An enhanced paracrine/autocrine activity of the insulin-like growth factor (IGF) system within the glomerulus has been implicated together with up-regulation of transforming growth factor-beta (TGFbeta) in the pathogenesis of diabetic glomerular disease. This would imply their ability to modulate extracellular matrix (ECM) and cell turnover at the mesangial level, but the direct effects of IGFs on ECM production have not been demonstrated to date. These experiments in cultured human mesangial cells were aimed at assessing the effects of IGF-I and IGF- II, compared with those of TGFbeta, on 1) ECM medium accumulation and gene expression, and 2) total protein synthesis and cell proliferation. Human mesangial cells were grown to subconfluence, growth arrested for 48 h, and then exposed for 4-24 h to serum-free medium containing IGF-I (10(-7) - 10(-11) M), IGF-II (10(-7) - 10(-11) M), TGFbeta (10(-9) - 10(-11) M), or various combinations of two of these growth factors (10(- 9)M). All three growth factors dose dependently increased ECM protein and messenger RNA levels. The combination of either IGF-I or IGF-II with TGFbeta, but not the two IGFs together, produced additive effects on matrix production. Total protein synthesis was also increased by IGF- I, IGF-II, and TGFbeta, although to a lesser extent than ECM production, whereas cell proliferation was enhanced by IGFs but not by TGFbeta. These results demonstrate that IGF-I and IGF-II are effective, although less potent than TGFbeta, in stimulating the production of the ECM components that accumulate in the mesangial region during the course of diabetic glomerular disease.

This article has been cited by other articles:

				D. Spentzos, S. A Cannistra, F. Grall, D. A Levine, K. Pillay, T. A Libermann, and C. S Mantzoros IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer Endocr. Relat. Cancer, September 1, 2007; 14(3): 781 - 790. [Abstract] [Full Text] [PDF]

				S. D. Oldroyd, Y. Miyamoto, A. Moir, T. S. Johnson, A. M. El Nahas, and J. L. Haylor An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy Am J Physiol Renal Physiol, March 1, 2006; 290(3): F695 - F702. [Abstract] [Full Text] [PDF]

				S. Lam, R. N. van der Geest, N. A.M. Verhagen, F. A. van Nieuwenhoven, I. E. Blom, J. Aten, R. Goldschmeding, M. R. Daha, and C. van Kooten Connective Tissue Growth Factor and IGF-I Are Produced by Human Renal Fibroblasts and Cooperate in the Induction of Collagen Production by High Glucose Diabetes, December 1, 2003; 52(12): 2975 - 2983. [Abstract] [Full Text] [PDF]

				J. L. Gooch, J. L. Barnes, S. Garcia, and H. E. Abboud Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation Am J Physiol Renal Physiol, January 1, 2003; 284(1): F144 - F154. [Abstract] [Full Text] [PDF]

				J. L. Gooch, Y. Tang, J. M. Ricono, and H. E. Abboud Insulin-like Growth Factor-I Induces Renal Cell Hypertrophy via a Calcineurin-dependent Mechanism J. Biol. Chem., November 2, 2001; 276(45): 42492 - 42500. [Abstract] [Full Text] [PDF]

				J. HAYLOR, H. HICKLING, E. EL ETER, A. MOIR, S. OLDROYD, C. HARDISTY, and A. M. EL NAHAS JB3, an IGF-I Receptor Antagonist, Inhibits Early Renal Growth in Diabetic and Uninephrectomized Rats J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2027 - 2035. [Abstract] [Full Text]

				J. A. DOUTHWAITE, T. S. JOHNSON, J. L. HAYLOR, P. WATSON, and A. M. E. NAHAS Effects of Transforming Growth Factor-{beta}1 on Renal Extracellular Matrix Components and Their Regulating Proteins J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2109 - 2119. [Abstract] [Full Text]

				S. Zaina, R. V. S. Newton, M. R. Paul, and C. F. Graham Local Reduction of Organ Size in Transgenic Mice Expressing a Soluble Insulin-Like Growth Factor II/Mannose-6-Phosphate Receptor Endocrinology, September 1, 1998; 139(9): 3886 - 3895. [Abstract] [Full Text] [PDF]

				M. J. Horney, D. W. Shirley, D. T. Kurtz, and S. A. Rosenzweig Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1045 - F1053. [Abstract] [Full Text] [PDF]